Application of modified antisense oligonucleotides and siRNAs as antiviral drugs

被引：14
|
作者：
Wagner, Anke [1 ]
Bock, Claus-Thomas [2 ]
Fechner, Henry [3 ]
Kurreck, Jens [3 ]
机构：
[1] Berlin Univ Technol, BioNukleo, Dept Bioproc Engn, Berlin, Germany
[2] Robert Koch Inst, Dept Infect Dis, Berlin, Germany
[3] Berlin Univ Technol, Inst Biotechnol, Dept Appl Biochem, Berlin, Germany
来源：
FUTURE MEDICINAL CHEMISTRY | 2015年 / 7卷 / 13期
关键词：
antisense oligonucleotide; antiviral therapy; delivery system; modified nucleotides; post-transcriptional gene silencing; siRNAs; EBOLA-VIRUS; RNA INTERFERENCE; DISCOVERY; INFECTION; PRIMATES;
D O I：
10.4155/fmc.15.114
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1637 / 1642
页数：6
相关论文
共 50 条
  • [21] Therapeutic Antisense Oligonucleotides Are Coming of Age
    Bennett, C. Frank
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 307 - 321
  • [22] Angiotensinogen antisense oligonucleotides and fluid intake
    Sinnayah, P
    McKinley, MJ
    Coghlan, JP
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (5-6) : 993 - 1007
  • [23] Antisense Oligonucleotides for the Study and Treatment of ALS
    Boros, Benjamin D.
    Schoch, Kathleen M.
    Kreple, Collin J.
    Miller, Timothy M.
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1145 - 1158
  • [24] Antisense oligonucleotides and their technical suitability to nebulization
    Seidl, Leonardo L.
    Moog, Regina
    Graeser, Kirsten A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 661
  • [25] Antisense Oligonucleotides for the Treatment of Hypertriglyceridemia and Hyperlipoproteinemia(a)
    Hanssen R.
    Gouni-Berthold I.
    Current Pharmacology Reports, 2017, 3 (6) : 458 - 468
  • [26] Topical and transdermal delivery of antisense oligonucleotides
    Brand, RM
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (03) : 244 - 248
  • [27] Synthesis of antisense oligonucleotides with minimum depurination
    Krotz, AH
    Cole, DL
    Ravikumar, VT
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (02): : 129 - 134
  • [28] Therapeutic antisense oligonucleotides for movement disorders
    Doxakis, Epaminondas
    MEDICINAL RESEARCH REVIEWS, 2021, 41 (05) : 2656 - 2688
  • [29] Antisense oligonucleotides: a promising therapeutic option against infectious diseases
    Tekintas, Yamac
    Temel, Aybala
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024, 43 (01): : 1 - 39
  • [30] Antisense Oligonucleotides for the Study and Treatment of ALS
    Benjamin D. Boros
    Kathleen M. Schoch
    Collin J. Kreple
    Timothy M. Miller
    Neurotherapeutics, 2022, 19 : 1145 - 1158
12345